Curis
CRIS
#11045
Rank
ยฃ3.91 M
Marketcap
ยฃ0.41
Share price
24.32%
Change (1 day)
-56.03%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -ยฃ6.55 Million

According to Curis's latest financial reports the company's current earnings are ยฃ4.31 Million. In 2025 the company made an earning of -ยฃ4.1 Million, an increase over its 2024 earnings that were of -ยฃ32.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ6.55 Million59.89%
2025 -ยฃ4.1 Million-87.38%
2024 -ยฃ32.46 Million-5.77%
2023 -ยฃ34.45 Million-13.1%
2022 -ยฃ39.64 Million27.52%
2021 -ยฃ31.09 Million65.09%
2020 -ยฃ18.83 Million-9.1%
2019 -ยฃ20.72 Million-4.73%
2018 -ยฃ21.74 Million-41.95%
2017 -ยฃ37.45 Million-14.37%
2016 -ยฃ43.74 Million3.55%
2015 -ยฃ42.23 Million271.52%
2014 -ยฃ11.37 Million76.64%
2013 -ยฃ6.44 Million
2011 -ยฃ5.47 Million27.76%
2010 -ยฃ4.28 Million-43.87%
2009 -ยฃ7.63 Million-23.44%
2008 -ยฃ9.96 Million56.66%
2007 -ยฃ6.36 Million-16.71%
2006 -ยฃ7.63 Million-36.92%
2005 -ยฃ12.1 Million156.25%
2004 -ยฃ4.72 Million-37.24%
2003 -ยฃ7.53 Million-93.34%
2002 -ยฃ0.12 Billion86.79%
2001 -ยฃ60.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ5.28 B-82,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.59 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ46.96 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.80 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.25 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ16.89 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ0.15 Billion 2,203.50%๐Ÿ‡บ๐Ÿ‡ธ USA